Prevention and Lipids - The effect of long-term exposure to lower LDL-C, lower SBP, or both on the risk of cardiovascular disease

Prevention and Lipids - OPTICARE - Benefits of the OPTImal CArdiac REhabilitation trial: an expanded educational and behavioral intervention

Prevention and Lipids - 2016 ESCAPE - Effect of alirocumab on the frequency of lipoprotein apheresis: a randomised Phase III trial

Prevention and Lipids - Apheresis as a novel treatment for refractory angina with raised lipoprotein(a): a randomised controlled trial

Coronary Artery Disease and Imaging - CONSERVE - Direct catheterization versus selective catheterization guided by Coronary CT in patients with stable suspected Coronary Artery Disease

Coronary Artery Disease and Imaging - CE-MARC 2 - A randomized trial of 3 diagnostic strategies in patients with suspected coronary heart disease

Coronary Artery Disease and Imaging - AMERICA - Systematic detection and management of multivascular involvement of atherothrombosis in coronary patients in comparison with treatment of coronary disease only

Heart Failure and Innovative Approaches - DANISH -assessing the efficacy of ICD in patients with non-ischemic systolic heart failure

Heart Failure and Innovative Approaches - REM-HF - Remote monitoring: an evaluation of implantable devices for management of heart failure patients

Heart Failure and Innovative Approaches - MORE-CARE - Effects of remote monitoring and use of healthcare resources in HF patients with biventricular defibrillators

Heart Failure and Innovative Approaches - CHART-1 - Phase 3 congestive heart failure cardiopoietic regenerative therapy

Heart Failure and Innovative Approaches - Safety and efficacy of intravenous infusion of ischemia tolerant allogeneic mesenchymal stem cells

Preventive Strategies I - ANTARCTIC - Platelet function monitoring in elderly patients stented for an acute coronary syndrome

Preventive Strategies I - NIPPON study: Optimal DAPT duration following drug eluting stent

Preventive Strategies I - SAVE - The sleep apnea cardiovascular endpoints study results

Preventive Strategies I - NACIAM Trial - The early use of NAC with GTN in ST-segment Elevation MI patients undergoing PCI

ANNEXA-4 Study; new antidote against Factor Xa inhibitors

Imaging of the heart: cardiac CT - indication, specificity, sensitivity, radiation dose, screening.

The New Heart Failure Guidelines

Daily use of the specific antidote of dabigatran

Game changing results in the field of ICD and cardiopoetic stem cell therapies

Where are we going with the NOAC-s; dabigatran's specific antidote

Unfavourable outcome after the upgrade of an implantable cardioverter defibrillator to cardiac resynchronization therapy

How long should we anticoagulate after pulmonary embolism

Prevention: the role of hypertension, and high lipid levels

Indepth analysis of the patient survival from the Hungarian Myocardial Infarction Registry and its role in the choice of anti-platelet agent.

Causative effect of LDL-C and sistolic bloodpressure in CV risk. Role of preventive strategies

Novelties about coronary artery disease and imaging technologies

Summary of the Preventive Strategies II. Hotline Session

Summary of the Preventive Strategies Hotline Session

Anticoagulant therapy with NOACs in AF and VTE; Dealing with patients with comorbidities

Novelties in the field of Coronary Artery Disease and Stenting